DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Insecticides (India) Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·7 Oct 2026, 4:32 am

Insecticides (I)

Insecticides (India) Limited has announced that it will hold a meeting with analysts and institutional investors. This event is scheduled to take place on the upcoming business day, as confirmed by the company's exchange filing. The meeting is intended to provide an opportunity for the management to discuss the company's current business performance and future outlook directly with the investment community.

For investors, this update is significant as it signals the company's willingness to engage with the market and share strategic insights. Such interactions often precede the release of quarterly results or major corporate announcements, offering a chance to gauge management sentiment and address queries from the broader investor base.

Investors should watch for any specific guidance or commentary regarding the company's operational performance and growth prospects during the discussion. While the meeting itself does not disclose new financial data, it provides valuable context that can help investors assess the company's trajectory ahead of any formal disclosures.